Skip to main content

Multiple lines of treatment improve OS in Castrate resistant prostate cancer

Akhtar
Mateen
Clinical Oncology
Colchester General Hospital
Colchester
Essex
Show all authors
Rubasingham
Jeffrey
Clinical Oncology
Colchester General Hospital
Colchester
Essex
Muthukumar
Dakshinamoorthy
Clinical Oncology
Colchester General Hospital
Colchester
Essex
United Kingdom
Mahmood
Rana
Clinical Oncology
Colchester General Hospital
Colchester
Essex
United Kingdom

Tabs

Speciality: 
Oncology (medical)
Keywords: 
castration resistant prostate cancer, chemotherapy, overall survival, Docetaxel